Output Explorer

Achieving Clarity, Renewing Confidence
INTRODUCTION
The PREMARIN" Family of Products offers significant relief from menopausal symptoms,
prevents rapid bone loss in the early postmenopausal years, and has been the standard of care for
managing the constellation of symptoms associated with postmenopausal estrogen loss for more
than 60 years. However, a recent report from the Women's Health Initiative has resulted in
confusion among health care providers and patients about the balance of risks and benefits
associated with the use of postmenopausal hormone therapy (HT). Now, more than ever,
physicians and other health care professionals need appropriate information on the benefits and
risks of the PREMARIN Family of Products to ensure that the standard of care for
postmenopausal health is adequately promoted and that patients receive accurate information and
individualized counseling about their personal risk-benefit profile.
In July 1997, Design Write initiated a comprehensive, peer-reviewed publication program in
support of the PREMARIN Family of Products. The specific objectives of this program were:
1) to increase physician awareness of the multitude of benefits that HT provides for
postmenopausal women; 2) to diminish the negative perceptions associated with estrogens; and
3) to blunt the competitive threat of new products introduced as alternatives to postmenopausal
HT.
The success of this initial endeavor has lead to the development and implementation of a number
of programs, including:
Over 40 peer-reviewed publications
More than 40 scientific abstracts and posters at national meetings
Council on Hormone Education
Sales training backgrounders and journal article responses
Advisory boards/expert forums (with executive summaries) on selective estrogen-receptor
modulators, lower-dose postmenopausal HT, acute cognitive symptoms, breast health, and
sexuality
Journal supplements
Internal white papers
.
Pharmaceutical compendia surveillance program
.
Publications management program
.
Editorial assistance for key advocates
.
Women's HOPE Study clinical trial publications and associated slide kits
Branded slide kit for the Visiting Speakers Bureau
Progestins slide kit disseminated by Global Medical Affairs
Source: https://www.industrydocuments.ucsf.edu/docs/fyvw0217
DWRITE 066196

Answer the question using only the OCR text from a single document page. Return only the answer, with no explanation. Preserve the answer wording from the OCR text when possible.